by Clinical Neuropsychologist Online | Saturday, September 12, 2026 | Dementia
Abstract INTRODUCTION Late-onset Alzheimer’s disease (LOAD) and major depressive disorder (MDD) share genetic etiologies. Here, we investigated brain transcriptomic landscapes to gain insights into shared and divergent molecular and biological etiologies across...
by Clinical Neuropsychologist Online | Saturday, September 12, 2026 | Dementia
Abstract INTRODUCTION Fluorodeoxyglucose (FDG) positron emission tomography (PET) is widely used for detecting metabolic changes associated with neurodegeneration in Alzheimer’s disease (AD) and other dementias but is costly and involves ionizing radiation. Here...
by Clinical Neuropsychologist Online | Saturday, September 12, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 9, September 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 12, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia
Dementia, Ahead of Print. Dementia-friendly videos are adapted audiovisual resources designed to support care for people living with moderate to severe dementia. Although evidence suggests these videos can enhance comfort, engagement, and communication, little is...
by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia
Abstract INTRODUCTION Metabolic dysfunction, altered adenosine signaling, and white matter abnormalities are implicated in tauopathies, but their relationship to network disconnection remains unclear. Myelinating oligodendrocytes may represent a metabolically...
